Back to companies
Adaptive Biotechnologies Corp
ADPTUSNASDAQPharmaceuticals & HealthcareAdaptive Biotechnologies Corp
Revenue
$277.0mn
YoY +54.8%
Operating income
-$57.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API